Skip to main content
Infant Bacterial Therapeutics logo

Infant Bacterial Therapeutics — Investor Relations & Filings

Ticker · IBT ISIN · SE0008015259 LEI · 2138008KVBXCRJGP6Z26 ST Manufacturing
Open in API
Filings indexed 212 across all filing types
Latest filing 2018-10-08 Board/Management Inform…
Country SE Sweden
Listing ST IBT

About Infant Bacterial Therapeutics

https://ibtherapeutics.com/

Infant Bacterial Therapeutics (IBT) is a pharmaceutical company that develops drugs influencing the human infant microbiome to prevent or treat rare diseases. The company's primary focus is on premature infants, addressing urgent medical needs such as necrotizing enterocolitis (NEC), a potentially lethal inflammatory bowel disorder. Its lead drug candidate, IBP-9414, is a New Biological Entity (NBE) currently in a Phase 3 clinical study. IBT also aims to develop treatments for diseases caused by antibiotic-resistant bacteria. The company is developing its medicines for approval by regulatory agencies, including the FDA and EMA.

Recent filings

Filing Released Lang Actions
Infant Bacterial Therapeutics AB (publ) meddelar att valberedning inför årsstämman 2019 tillsatts
Board/Management Information Classification · 99% confidence The document is a press release dated October 8, 2018, announcing the composition of the Nomination Committee (Valberedning) for the upcoming Annual General Meeting (AGM) in 2019. This committee is responsible for proposing board members and auditors for the AGM. While it relates to the AGM, the core content is the announcement of the composition of a specific committee responsible for board nominations, which falls under governance or board-related information. However, none of the specific codes perfectly match 'Nomination Committee Announcement'. Let's evaluate the closest fits: 1. AGM-R: This is for AGM presentations/materials, not the pre-meeting committee announcement. 2. MANG (Board/Management Information): This covers changes in the board or senior management. The nomination committee selection directly impacts future board composition. 3. CGR (Governance Information): This covers internal rules and board structure. The nomination committee structure is a key governance element. Given that the announcement explicitly details the composition of the committee tasked with nominating directors for the AGM, it is most closely related to Board/Management Information (MANG) or Governance Information (CGR). Since the text focuses on the *process* of selecting future board members via the nomination committee, MANG seems slightly more appropriate than the broader CGR, although CGR is also plausible. However, looking closely at the definitions, there is no specific code for 'Nomination Committee Announcement'. Since the committee's primary function is to nominate directors, MANG (Announcement of changes in the company's board of directors or senior management) is the best fit, as this sets up the slate for the next board election. Revisiting the definitions, the document is an announcement about the *formation* of the committee that will propose board members. This is a procedural step related to governance and board structure. If we consider the closest fit among the provided options, MANG relates to changes in the board itself, while CGR relates to governance practices. Since this is a procedural announcement setting up the next board election, I will classify it as Governance Information (CGR) as it details a key structural element of corporate governance related to board appointments.
2018-10-08 Swedish
Infant Bacterial Therapeutics AB (publ) announces that the Nomination Committee is appointed for the Annual General Meeting 2019
Board/Management Information Classification · 99% confidence The document is a press release dated October 8, 2018, announcing the appointment of the Nomination Committee for the upcoming Annual General Meeting (AGM) in 2019. This announcement directly relates to the preparatory steps and governance structure surrounding the AGM, specifically concerning the nomination of future board members/committee members. This falls under the scope of AGM-related information, which is classified as 'AGM Information' (AGM-R). It is not the AGM presentation itself, but a formal announcement regarding its governance structure.
2018-10-08 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.